Follow
Jeffrey Trocio
Jeffrey Trocio
Verified email at pfizer.com
Title
Cited by
Cited by
Year
Patient‐reported reasons for discontinuing overactive bladder medication
JS Benner, MB Nichol, ES Rovner, Z Jumadilova, J Alvir, M Hussein, ...
BJU international 105 (9), 1276-1282, 2010
4462010
Estimated prevalence of undiagnosed atrial fibrillation in the United States
MP Turakhia, J Shafrin, K Bognar, J Trocio, Y Abdulsattar, D Wiederkehr, ...
PloS one 13 (4), e0195088, 2018
1882018
DermaVir: a novel topical vaccine for HIV/AIDS
J Lisziewicz, J Trocio, L Whitman, G Varga, J Xu, N Bakare, P Erbacher, ...
Journal of investigative dermatology 124 (1), 160-169, 2005
1332005
Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records
M Sussman, J Trocio, C Best, S Mirkin, AG Bushmakin, R Yood, ...
BMC Women's Health 15, 1-5, 2015
1182015
Economic burden of undiagnosed nonvalvular atrial fibrillation in the United States
MP Turakhia, J Shafrin, K Bognar, DP Goldman, PM Mendys, ...
The American journal of cardiology 116 (5), 733-739, 2015
1082015
Control of viral rebound through therapeutic immunization with DermaVir
J Lisziewicz, J Trocio, J Xu, L Whitman, A Ryder, N Bakare, MG Lewis, ...
Aids 19 (1), 35-43, 2005
962005
Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients
S Deitelzweig, X Luo, K Gupta, J Trocio, J Mardekian, T Curtice, ...
Current medical research and opinion 33 (10), 1745-1754, 2017
852017
Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared …
A Amin, A Keshishian, J Trocio, O Dina, H Le, L Rosenblatt, X Liu, ...
Current medical research and opinion 33 (9), 1595-1604, 2017
772017
Challenges for managing overactive bladder and guidance for patient support
VF Schabert, T Bavendam, EL Goldberg, JN Trocio, L Brubaker
Am J Manag Care 15 (4 Suppl), S118-22, 2009
652009
IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine
SA Calarota, A Dai, JN Trocio, DB Weiner, F Lori, J Lisziewicz
Vaccine 26 (40), 5188-5195, 2008
552008
DermaVir, a novel HIV immunisation technology
F Lori, J Trocio, N Bakare, LM Kelly, J Lisziewicz
Vaccine 23 (17-18), 2030-2034, 2005
542005
Predictors of discontinuing overactive bladder medications
L Brubaker, K Fanning, EL Goldberg, JS Benner, JN Trocio, T Bavendam, ...
BJU international 105 (9), 1283-1290, 2010
512010
An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants
S Deitelzweig, A Bruno, J Trocio, N Tate, K Gupta, J Lin, M Lingohr-Smith
Current medical research and opinion 32 (3), 573-582, 2016
502016
Real-world comparative effectiveness, safety, and health care costs of oral anticoagulants in nonvalvular atrial fibrillation patients in the US Department of Defense Population
K Gupta, J Trocio, A Keshishian, Q Zhang, O Dina, J Mardekian, ...
Journal of managed care & specialty pharmacy 24 (11), 1116-1127, 2018
442018
Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism …
A Amin, A Bruno, J Trocio, J Lin, M Lingohr-Smith
Journal of Medical Economics 18 (6), 399-409, 2015
432015
HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3
AD Cristillo, J Lisziewicz, L He, F Lori, L Galmin, JN Trocio, T Unangst, ...
Virology 366 (1), 197-211, 2007
422007
Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: a decision-tree model
S Arlandis-Guzman, C Errando-Smet, J Trocio, D Arumi, J Rejas
BMC urology 11, 1-11, 2011
382011
Linguistic validation of translation of the self-assessment goal achievement (saga) questionnaire from English
E Piault, S Doshi, BA Brandt, Ç Angün, CJ Evans, A Bergqvist, J Trocio
Health and quality of life outcomes 10, 1-9, 2012
352012
Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting
J Lin, J Trocio, K Gupta, J Mardekian, M Lingohr-Smith, B Menges, M You, ...
Journal of medical economics 20 (9), 952-961, 2017
332017
Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire
L Brubaker, V Khullar, E Piault, CJ Evans, T Bavendam, J Beach, Y Yeh, ...
International urogynecology journal 22, 937-946, 2011
332011
The system can't perform the operation now. Try again later.
Articles 1–20